Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilhem Solé

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Journal of Neurology|May 30, 2024
The various forms of hereditary motor neuron disorders and their historical descriptionsStéphane Mathis, Diane Beauvais, Fanny Duval, et al.
Journal of Neurology|June 20, 2020
The ataxic neuropathiesStéphane Mathis, Fanny Duval, Antoine Soulages, et al.
Neuromuscular Disorders : NMD|December 23, 2018
A novel nonsense PIEZO2 mutation in a family with scoliosis and proprioceptive defectMarion Masingue, Julien Fauré, Guilhem Solé, et al.
Journal of Neurology|June 21, 2024
Clinical and pathological aspects of toxic myopathiesMégane Le Quang, Guilhem Solé, Marie-Laure Martin-Négrier, et al.
Journal of Neurology|August 22, 2022
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort studyMarlène Barnay, Fanny Duval, Guilhem Solé, et al.
Journal of the Neurological Sciences|October 16, 2022
Acute peripheral neuropathy following animal envenomation: A case report and systematic reviewStéphane Mathis, Louis Carla, Fanny Duval, et al.
La Revue De Medecine Interne|April 8, 2026
[The management of glucocorticoid-induced myopathy]Guilhem Solé, Stéphane Mathis, Mégane Le Quang, et al.
European Journal of Neurology|November 4, 2024
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims databaseShahram Attarian, Jean-Philippe Camdessanché, Andoni Echaniz-Laguna, et al.
Journal of the Neurological Sciences|April 13, 2021
Olfaction and anosmia: From ancient times to COVID-19Stéphane Mathis, Gwendal Le Masson, Antoine Soulages, et al.
Brain and Behavior|February 28, 2018
Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysisGwendal Le Masson, Guilhem Solé, Claude Desnuelle, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Neurology|May 30, 2024
The various forms of hereditary motor neuron disorders and their historical descriptionsStéphane Mathis, Diane Beauvais, Fanny Duval, et al.
Journal of Neurology|June 20, 2020
The ataxic neuropathiesStéphane Mathis, Fanny Duval, Antoine Soulages, et al.
Neuromuscular Disorders : NMD|December 23, 2018
A novel nonsense PIEZO2 mutation in a family with scoliosis and proprioceptive defectMarion Masingue, Julien Fauré, Guilhem Solé, et al.
Journal of Neurology|June 21, 2024
Clinical and pathological aspects of toxic myopathiesMégane Le Quang, Guilhem Solé, Marie-Laure Martin-Négrier, et al.
Journal of Neurology|August 22, 2022
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort studyMarlène Barnay, Fanny Duval, Guilhem Solé, et al.
Journal of the Neurological Sciences|October 16, 2022
Acute peripheral neuropathy following animal envenomation: A case report and systematic reviewStéphane Mathis, Louis Carla, Fanny Duval, et al.
La Revue De Medecine Interne|April 8, 2026
[The management of glucocorticoid-induced myopathy]Guilhem Solé, Stéphane Mathis, Mégane Le Quang, et al.
European Journal of Neurology|November 4, 2024
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims databaseShahram Attarian, Jean-Philippe Camdessanché, Andoni Echaniz-Laguna, et al.
Journal of the Neurological Sciences|April 13, 2021
Olfaction and anosmia: From ancient times to COVID-19Stéphane Mathis, Gwendal Le Masson, Antoine Soulages, et al.
Brain and Behavior|February 28, 2018
Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysisGwendal Le Masson, Guilhem Solé, Claude Desnuelle, et al.
Pageof 7